Proctor & Gamble raising prices as inflation persists
Proctor & Gamble is raising prices over the next few months, due to outside inflationary pressures and falling sales and revenue.
COVID vaccine mandates hurt the doctor-patient relationship: Dr. Frank Contacessa
MDVIP internist Dr. Frank Contacessa reacts to Gov. DeSantis moving to permanently ban COVID mandates in Florida on 'Varney & Co.'
Ozempic shortage a 'serious problem' for diabetics: Dr. Bob Lahita
St. Joseph Health Institute director Dr. Bob Lahita discusses how the Ozempic craze is causing issues for diabetics and addresses the rise in medical costs on 'Varney & Co.'
Wilbur Ross talks new investment
Former Secretary of Commerce Wilbur Ross announced a business combination agreement between Aprinoia Therapeutics and Ross Acquisition Corp to create a publicly listed company focused on neurodegenerative diseases.
Scientists reverse the aging process in mice, are humans next?
Dr. Marty Makary discusses new research that shows scientists have made inroads into reversing the aging process on 'Varney & Co.'
J&J slashes production of its unpopular COVID-19 shot
A partnership with rival Merck & Co. to help make the shots, forged at the urging of the U.S. government, hasn’t lived up to expectations. The companies are now engaged in arbitration.
Moderna CEO talks company transformation: 'This wasn’t going to be a one drug company'
Moderna CEO Stephane Bancel joins 'Mornings with Maria' to discuss how it transformed during the pandemic and its lawsuit against Pfizer.
Alphabet unit Verily to trim more than 200 jobs
Verily Life Sciences, formerly Google Life Sciences, a health care company and one of the largest under Google parent Alphabet's, umbrella, will lay off 15%.
FDA approves Biogen, Eisai Alzheimer’s drug
An Alzheimer’s drug from Biogen and Eisai has received accelerated approval from the Food and Drug Administration, the companies and agency announced Friday.
Shares of GE's health care spinoff make trading debut on Nasdaq
Trading of GE HealthCare Technologies shares kicked off Wednesday morning, marking its debut as an independent company from conglomerate General Electric.
Nationwide crime spike continues to burden frontline hospital staff
FOX Business’ Lydia Hu reports on the rise in violent crimes that has started to overwhelm hospitals and emergency rooms across the country on ‘Varney & Co.’
Baby-formula imports to face tariffs again in 2023
Tariffs on baby formula are set to resume in the new year, despite supply chain issues and some still empty shelves.
Company recalling blood pressure pills because of potential impurity presence
The potential presence of a nitrosamine impurity has prompted Lupin Pharmaceuticals to issue a recall of some blood pressure medication, per an announcement.
Masimo's W1 invented to do things the Apple Watch can't: CEO Joe Kiani
Masimo CEO Joe Kiani explains how the medical device maker plans to take on the Apple Watch on 'The Claman Countdown.'
J&J and Merck Ebola vaccines produce lasting antibodies in children and adults
According to a study published in The New England Journal of Medicine, the Johnson & Johnson's and Merck's vaccines for Ebola created lasting antibodies.
DeSantis calls for Florida grand jury to investigate coronavirus vaccine 'wrongdoing'
Florida Gov. Ron DeSantis, during a panel about reported side effects of coronavirus vaccines, says he wants a statewide grand jury to investigate any "wrongdoing" surrounding them.
Moderna and Merck team-up to fight melanoma
Vaccine-maker Moderna has partnered with the biopharmaceutical company Merck to create an effective treatment for skin cancer
Can't find children's Tylenol? You might not need it, doctors say
The surge of viral illnesses in children nationwide, driven by cases of RSV, flu and COVID-19, is causing high demand for certain medicine including children's Tylenol.
Juul Labs will pay $1.2B for role in youth-vaping epidemic
Juul Labs gets equity investment to pay $1.2 billion in settlements for contributing to America’s youth vaping epidemic.
BioVie: Treating Alzheimer's, Parkinson's potentially reversing the aging process
BioVie president and CEO Cuong Do discusses the positive results of its Parkinson's and Alzheimer's phase 2 trials and explains how its NE3107 drug could reverse the biological clock on 'Varney & Co.'